Antibody for Alzheimer’s

Israel’s ImmunoBrain Checkpoint aims to begin trials of its IBC-Ab002 treatment for Alzheimer’s disease. The antibody, developed by its Chief Scientist EMET Prize-winning Weizmann Institute Professor Michal Schwartz, boosts the immune system to induce brain repair processes.

https://www.jpost.com/health-science/israeli-revolutionary-alzheimers-treatment-to-launch-phase-1-trial-641848

https://www.ibcheckpoint.com/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *